2.3.0.11 Html 208 308 1 true 68 0 false 4 true false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biomedrealty.com/role/DocumentDocumentAndEntityInformation Document and Entity Information false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.biomedrealty.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.biomedrealty.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Consolidated Statements of Income Sheet http://www.biomedrealty.com/role/StatementConsolidatedStatementsOfIncome Consolidated Statements of Income false false R5.htm 00300 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.biomedrealty.com/role/StatementConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income false false R6.htm 00400 - Statement - Consolidated Statements of Equity Sheet http://www.biomedrealty.com/role/StatementConsolidatedStatementsOfEquity Consolidated Statements of Equity false false R7.htm 00500 - Statement - Consolidated Statements of Cash Flows Sheet http://www.biomedrealty.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R8.htm 00505 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.biomedrealty.com/role/StatementConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) false false R9.htm 10101 - Disclosure - Organization of the Parent Company and Description of Business Sheet http://www.biomedrealty.com/role/DisclosureOrganizationOfParentCompanyAndDescriptionOfBusiness Organization of the Parent Company and Description of Business false false R10.htm 10201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies false false R11.htm 10301 - Disclosure - Equity of the Parent Company Sheet http://www.biomedrealty.com/role/DisclosureEquityOfParentCompany Equity of the Parent Company false false R12.htm 10401 - Disclosure - Capital of the Operating Partnership Sheet http://www.biomedrealty.com/role/DisclosureCapitalOfOperatingPartnership Capital of the Operating Partnership false false R13.htm 10501 - Disclosure - Debt Sheet http://www.biomedrealty.com/role/DisclosureDebt Debt false false R14.htm 10601 - Disclosure - Earnings Per Share of the Parent Company Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerShareOfParentCompany Earnings Per Share of the Parent Company false false R15.htm 10701 - Disclosure - Earnings Per Unit of the Operating Partnership Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerUnitOfOperatingPartnership Earnings Per Unit of the Operating Partnership false false R16.htm 10801 - Disclosure - Investment in Unconsolidated Partnerships Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnerships Investment in Unconsolidated Partnerships false false R17.htm 10901 - Disclosure - Derivatives and Other Financial Instruments Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstruments Derivatives and Other Financial Instruments false false R18.htm 11001 - Disclosure - Fair-Value of Financial Instruments Sheet http://www.biomedrealty.com/role/DisclosureFairValueOfFinancialInstruments Fair-Value of Financial Instruments false false R19.htm 20202 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policy) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicy Basis of Presentation and Summary of Significant Accounting Policies (Policy) false false R20.htm 30203 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) false false R21.htm 30303 - Disclosure - Equity of the Parent Company (Tables) Sheet http://www.biomedrealty.com/role/DisclosureEquityOfParentCompanyTables Equity of the Parent Company (Tables) false false R22.htm 30503 - Disclosure - Debt (Tables) Sheet http://www.biomedrealty.com/role/DisclosureDebtTables Debt (Tables) false false R23.htm 30603 - Disclosure - Earnings Per Share of the Parent Company (Tables) Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerShareOfParentCompanyTables Earnings Per Share of the Parent Company (Tables) false false R24.htm 30703 - Disclosure - Earnings Per Unit of the Operating Partnership (Tables) Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerUnitOfOperatingPartnershipTables Earnings Per Unit of the Operating Partnership (Tables) false false R25.htm 30803 - Disclosure - Investment in Unconsolidated Partnerships (Tables) Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnershipsTables Investment in Unconsolidated Partnerships (Tables) false false R26.htm 30903 - Disclosure - Derivatives and Other Financial Instruments (Tables) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsTables Derivatives and Other Financial Instruments (Tables) false false R27.htm 31003 - Disclosure - Fair-Value of Financial Instruments (Tables) Sheet http://www.biomedrealty.com/role/DisclosureFairValueOfFinancialInstrumentsTables Fair-Value of Financial Instruments (Tables) false false R28.htm 40101 - Disclosure - Organization of the Parent Company and Description of Business (Details) Sheet http://www.biomedrealty.com/role/DisclosureOrganizationOfParentCompanyAndDescriptionOfBusinessDetails Organization of the Parent Company and Description of Business (Details) false false R29.htm 40201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesNarrativeDetails Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) false false R30.htm 40202 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Selected Financial Data of the VIEs) (Details) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesSelectedFinancialDataOfViesDetails Basis of Presentation and Summary of Significant Accounting Policies (Selected Financial Data of the VIEs) (Details) false false R31.htm 40203 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Investments in Real Estate) (Details) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesInvestmentsInRealEstateDetails Basis of Presentation and Summary of Significant Accounting Policies (Investments in Real Estate) (Details) false false R32.htm 40204 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Deferred Leasing Costs) (Details) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesDeferredLeasingCostsDetails Basis of Presentation and Summary of Significant Accounting Policies (Deferred Leasing Costs) (Details) false false R33.htm 40205 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Investments Included in Other Assets) (Details) Sheet http://www.biomedrealty.com/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesInvestmentsIncludedInOtherAssetsDetails Basis of Presentation and Summary of Significant Accounting Policies (Investments Included in Other Assets) (Details) false false R34.htm 40301 - Disclosure - Equity of the Parent Company (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureEquityOfParentCompanyNarrativeDetails Equity of the Parent Company (Narrative) (Details) false false R35.htm 40302 - Disclosure - Equity of the Parent Company (Dividends and Distributions) (Details) Sheet http://www.biomedrealty.com/role/DisclosureEquityOfParentCompanyDividendsAndDistributionsDetails Equity of the Parent Company (Dividends and Distributions) (Details) false false R36.htm 40303 - Disclosure - Equity of the Parent Company (Vested Ownership Interests) (Details) Sheet http://www.biomedrealty.com/role/DisclosureEquityOfParentCompanyVestedOwnershipInterestsDetails Equity of the Parent Company (Vested Ownership Interests) (Details) false false R37.htm 40401 - Disclosure - Capital of the Operating Partnership (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureCapitalOfOperatingPartnershipNarrativeDetails Capital of the Operating Partnership (Narrative) (Details) false false R38.htm 40501 - Disclosure - Debt (Exchangeable Senior Notes Due 2030) (Narrative) (Details) Notes http://www.biomedrealty.com/role/DisclosureDebtExchangeableSeniorNotesDue2030NarrativeDetails Debt (Exchangeable Senior Notes Due 2030) (Narrative) (Details) false false R39.htm 40502 - Disclosure - Debt (Unsecured Senior Notes Due 2016, Net) (Narrative) (Details) Notes http://www.biomedrealty.com/role/DisclosureDebtUnsecuredSeniorNotesDue2016NetNarrativeDetails Debt (Unsecured Senior Notes Due 2016, Net) (Narrative) (Details) false false R40.htm 40503 - Disclosure - Debt (Subsequent Events - New Unsecured Line of Credit) (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDebtSubsequentEventsNewUnsecuredLineOfCreditNarrativeDetails Debt (Subsequent Events - New Unsecured Line of Credit) (Narrative) (Details) false false R41.htm 40504 - Disclosure - Debt (Outstanding Consolidated Mortgage Notes Payable) (Details) Notes http://www.biomedrealty.com/role/DisclosureDebtOutstandingConsolidatedMortgageNotesPayableDetails Debt (Outstanding Consolidated Mortgage Notes Payable) (Details) false false R42.htm 40505 - Disclosure - Debt (Principal Payments due for Operating Partnership's Consolidated Indebtedness) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDebtPrincipalPaymentsDueForOperatingPartnershipSConsolidatedIndebtednessDetails Debt (Principal Payments due for Operating Partnership's Consolidated Indebtedness) (Details) false false R43.htm 40601 - Disclosure - Earnings Per Share of the Parent Company (Computations of Basic and Diluted Earnings Per Share) (Details) Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerShareOfParentCompanyComputationsOfBasicAndDilutedEarningsPerShareDetails Earnings Per Share of the Parent Company (Computations of Basic and Diluted Earnings Per Share) (Details) false false R44.htm 40701 - Disclosure - Earnings Per Unit of the Operating Partnership (Computations of Basic and Diluted Earnings Per Unit) (Details) Sheet http://www.biomedrealty.com/role/DisclosureEarningsPerUnitOfOperatingPartnershipComputationsOfBasicAndDilutedEarningsPerUnitDetails Earnings Per Unit of the Operating Partnership (Computations of Basic and Diluted Earnings Per Unit) (Details) false false R45.htm 40801 - Disclosure - Investment in Unconsolidated Partnerships (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnershipsNarrativeDetails Investment in Unconsolidated Partnerships (Narrative) (Details) false false R46.htm 40802 - Disclosure - Investment in Unconsolidated Partnerships (Summary of Unconsolidated Partnerships) (Details) Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnershipsSummaryOfUnconsolidatedPartnershipsDetails Investment in Unconsolidated Partnerships (Summary of Unconsolidated Partnerships) (Details) false false R47.htm 40803 - Disclosure - Investment in Unconsolidated Partnerships (Summary of Selected Balance Sheet information) (Details) Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnershipsSummaryOfSelectedBalanceSheetInformationDetails Investment in Unconsolidated Partnerships (Summary of Selected Balance Sheet information) (Details) false false R48.htm 40804 - Disclosure - Investment in Unconsolidated Partnerships (Summary of Selected Income Statement information) (Details) Sheet http://www.biomedrealty.com/role/DisclosureInvestmentInUnconsolidatedPartnershipsSummaryOfSelectedIncomeStatementInformationDetails Investment in Unconsolidated Partnerships (Summary of Selected Income Statement information) (Details) false false R49.htm 40901 - Disclosure - Derivatives and Other Financial Instruments (Narrative) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsNarrativeDetails Derivatives and Other Financial Instruments (Narrative) (Details) false false R50.htm 40902 - Disclosure - Derivatives and Other Financial Instruments (Summary of Interest Rate Swaps and Stock Purchase Warrants Fair Value) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsSummaryOfInterestRateSwapsAndStockPurchaseWarrantsFairValueDetails Derivatives and Other Financial Instruments (Summary of Interest Rate Swaps and Stock Purchase Warrants Fair Value) (Details) false false R51.htm 40903 - Disclosure - Derivatives and Other Financial Instruments (Summary of the Amount of Gain Recognized in Comprehensive Income Related to Derivative Instruments) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsSummaryOfAmountOfGainRecognizedInComprehensiveIncomeRelatedToDerivativeInstrumentsDetails Derivatives and Other Financial Instruments (Summary of the Amount of Gain Recognized in Comprehensive Income Related to Derivative Instruments) (Details) false false R52.htm 40904 - Disclosure - Derivatives and Other Financial Instruments (Summary of Amount of Loss Reclassified from Other Comprehensive Income to Income) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsSummaryOfAmountOfLossReclassifiedFromOtherComprehensiveIncomeToIncomeDetails Derivatives and Other Financial Instruments (Summary of Amount of Loss Reclassified from Other Comprehensive Income to Income) (Details) false false R53.htm 40905 - Disclosure - Derivatives and Other Financial Instruments (Summary of Amount of Gain/(Loss) Recognized in Income as Loss on Derivative Instruments) (Details) Sheet http://www.biomedrealty.com/role/DisclosureDerivativesAndOtherFinancialInstrumentsSummaryOfAmountOfGainLossRecognizedInIncomeAsLossOnDerivativeInstrumentsDetails Derivatives and Other Financial Instruments (Summary of Amount of Gain/(Loss) Recognized in Income as Loss on Derivative Instruments) (Details) false false R54.htm 41001 - Disclosure - Fair-Value of Financial Instruments (Fair Value and Carrying Amount of the Company's Financial Instruments) (Details) Sheet http://www.biomedrealty.com/role/DisclosureFairValueOfFinancialInstrumentsFairValueAndCarryingAmountOfCompanySFinancialInstrumentsDetails Fair-Value of Financial Instruments (Fair Value and Carrying Amount of the Company's Financial Instruments) (Details) false false All Reports Book All Reports Element us-gaap_EquityMethodInvestments had a mix of decimals attribute values: 0 -3. Element us-gaap_EquityMethodInvestmentOwnershipPercentage had a mix of decimals attribute values: 4 3. Element us-gaap_EquityMethodInvestmentOwnershipPercentage had a mix of decimals attribute values: 4 3. Element us-gaap_DebtInstrumentCarryingAmount had a mix of decimals attribute values: -3 -5. Element us-gaap_DebtInstrumentCarryingAmount had a mix of decimals attribute values: -3 -5. Element us-gaap_DebtInstrumentCarryingAmount had a mix of decimals attribute values: -3 -5. Element us-gaap_EquityMethodInvestments had a mix of decimals attribute values: 0 -3. Element us-gaap_EquityMethodInvestmentOwnershipPercentage had a mix of decimals attribute values: 4 3. Element us-gaap_EquityMethodInvestments had a mix of decimals attribute values: 0 -3. Element us-gaap_NotionalAmountOfDerivatives had a mix of decimals attribute values: -3 -5. Element us-gaap_NotionalAmountOfDerivatives had a mix of decimals attribute values: -3 -5. 'Monetary' elements on report '00100 - Statement - Consolidated Balance Sheets' had a mix of different decimal attribute values. 'Monetary' elements on report '40503 - Disclosure - Debt (Subsequent Events - New Unsecured Line of Credit) (Narrative) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40504 - Disclosure - Debt (Outstanding Consolidated Mortgage Notes Payable) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40505 - Disclosure - Debt (Principal Payments due for Operating Partnership's Consolidated Indebtedness) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40803 - Disclosure - Investment in Unconsolidated Partnerships (Summary of Selected Balance Sheet information) (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40901 - Disclosure - Derivatives and Other Financial Instruments (Narrative) (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Consolidated Statements of Income Process Flow-Through: 00300 - Statement - Consolidated Statements of Comprehensive Income Process Flow-Through: 00500 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: 00505 - Statement - Consolidated Statements of Cash Flows (Parenthetical) bmr-20110630.xml bmr-20110630.xsd bmr-20110630_cal.xml bmr-20110630_def.xml bmr-20110630_lab.xml bmr-20110630_pre.xml true true